Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.
Journal: Clinical breast cancer
Published: November 14, 2018
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 12, 2017
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
Journal: Breast cancer research and treatment
Published: September 18, 2017
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: October 09, 2016
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
Journal: Clinical breast cancer
Published: February 27, 2016
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 11, 2015
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Journal: The Lancet. Oncology
Published: September 07, 2013
Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026